Abstract
Tiamulin is a semisynthetic diterpene antibiotic frequently used in farm animals. The drug has been shown to produce clinically important--often lethal--interactions with other compounds. It has been suggested that this is caused by a selective inhibition of oxidative drug metabolism via the formation of a cytochrome P-450 metabolic intermediate complex. In the present study, rats were treated orally for 6 days with tiamulin at two different doses: 40 and 226 mg/kg of body weight. For comparison, another group received 300 mg of triacetyloleandomycin (TAO) per kg, which is equivalent to the 226-mg/kg tiamulin group. Subsequently, microsomal P-450 contents, P-450 enzyme activities, metabolic intermediate complex spectra, and P-450 apoprotein concentrations were assessed. In addition, effects on individual microsomal P-450 activities were studied in control microsomes at different tiamulin and substrate concentrations. In the rats treated with tiamulin, a dose-dependent complex formation as evidenced by its absorption spectrum and an increase in cytochrome P-4503A1/2 contents as assessed by Western blotting (immunoblotting) were found. The effects were comparable to those of TAO. Tiamulin induced microsomal P-450 content, testosterone 6 beta-hydroxylation rate, erythromycin N-demethylation rate, and the ethoxyresorufin O-deethylation activity. Other activities were not affected or decreased. When tiamulin was added to microsomes of control rats, the testosterone 6 beta-hydroxylation rate and the erythromycin N-demethylation were strongly inhibited. It is concluded that tiamulin is a potent and selective inducer-inhibitor of cytochrome P-450. Though not belonging to the macrolides, the compound produces an effect on P-450 similar to those of TAO and related compounds.
Full Text
The Full Text of this article is available as a PDF (219.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arlotto M. P., Trant J. M., Estabrook R. W. Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. Methods Enzymol. 1991;206:454–462. doi: 10.1016/0076-6879(91)06114-i. [DOI] [PubMed] [Google Scholar]
- Bandiera S. Expression and catalysis of sex-specific cytochrome P450 isozymes in rat liver. Can J Physiol Pharmacol. 1990 Jun;68(6):762–768. doi: 10.1139/y90-117. [DOI] [PubMed] [Google Scholar]
- Burke M. D., Thompson S., Weaver R. J., Wolf C. R., Mayer R. T. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol. 1994 Aug 30;48(5):923–936. doi: 10.1016/0006-2952(94)90363-8. [DOI] [PubMed] [Google Scholar]
- De Groene E. M., Nijmeijer S. M., Horbach G. J., Witkamp R. F. Tiamulin inhibits human CYP3A4 activity in an NIH/3T3 cell line stably expressing CYP3A4 cDNA. Biochem Pharmacol. 1995 Sep 7;50(6):771–773. doi: 10.1016/0006-2952(95)00197-8. [DOI] [PubMed] [Google Scholar]
- Delaforge M., Ladam P., Bouillé G., Benarous J. G., Jaouen M., Girault J. P. pH effects on the N-demethylation and formation of the cytochrome P-450 iron II nitrosoalkane complex for erythromycin derivatives. Chem Biol Interact. 1992 Dec;85(2-3):215–227. doi: 10.1016/0009-2797(92)90063-q. [DOI] [PubMed] [Google Scholar]
- Franklin M. R. Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds. Methods Enzymol. 1991;206:559–573. doi: 10.1016/0076-6879(91)06126-n. [DOI] [PubMed] [Google Scholar]
- Funae Y., Imaoka S. Purification and characterization of liver microsomal cytochrome P-450 from untreated male rats. Biochim Biophys Acta. 1987 Dec 7;926(3):349–358. doi: 10.1016/0304-4165(87)90221-2. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lindstrom T. D., Hanssen B. R., Wrighton S. A. Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers. Antimicrob Agents Chemother. 1993 Feb;37(2):265–269. doi: 10.1128/aac.37.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller D. J., O'Connor J. J., Roberts N. L. Tiamulin/salinomycin interactions in pigs. Vet Rec. 1986 Jan 18;118(3):73–75. doi: 10.1136/vr.118.3.73. [DOI] [PubMed] [Google Scholar]
- NASH T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J. 1953 Oct;55(3):416–421. doi: 10.1042/bj0550416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993 Jan-Feb;12(1):1–51. doi: 10.1089/dna.1993.12.1. [DOI] [PubMed] [Google Scholar]
- Noordhoek J., van den Berg A. P., Savenije-Chapel E. M., Koopman-Kool E. Sex differences in the kinetic constants of ethylmorphine demethylation and type I binding to hepatic microsomal cytochrome P-450 in mice. The influence of castration and testosterone. Xenobiotica. 1978 Aug;8(8):515–522. doi: 10.3109/00498257809056154. [DOI] [PubMed] [Google Scholar]
- Pott J. M., Shov B. Monensin--tiamulin interactions in pigs. Vet Rec. 1981 Dec 12;109(24):545–545. [PubMed] [Google Scholar]
- Roos P. H., Golub-Ciosk B., Kallweit P., Kauczinski D., Hanstein W. G. Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes. Biochem Pharmacol. 1993 Jun 9;45(11):2239–2250. doi: 10.1016/0006-2952(93)90195-3. [DOI] [PubMed] [Google Scholar]
- Rutten A. A., Falke H. E., Catsburg J. F., Topp R., Blaauboer B. J., van Holsteijn I., Doorn L., van Leeuwen F. X. Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Reinvestigation of assay conditions. Arch Toxicol. 1987;61(1):27–33. doi: 10.1007/BF00324544. [DOI] [PubMed] [Google Scholar]
- Rutten A. A., Falke H. E., Catsburg J. F., Wortelboer H. M., Blaauboer B. J., Doorn L., van Leeuwen F. X., Theelen R., Rietjens I. M. Interlaboratory comparison of microsomal ethoxyresorufin and pentoxyresorufin O-dealkylation determinations: standardization of assay conditions. Arch Toxicol. 1992;66(4):237–244. doi: 10.1007/BF02307168. [DOI] [PubMed] [Google Scholar]
- Schuster I., Fleschurz C., Helm I. On the interaction of a lipophilic drug with different sites of rat-liver microsomes. Equilibrium studies with a substituted pleuromutilin. Eur J Biochem. 1975 Feb 21;51(2):511–519. doi: 10.1111/j.1432-1033.1975.tb03951.x. [DOI] [PubMed] [Google Scholar]
- Witkamp R. F., Nijmeijer S. M., Csikó G., van Miert A. S. Tiamulin selectively inhibits oxidative hepatic steroid and drug metabolism in vitro in the pig. J Vet Pharmacol Ther. 1994 Aug;17(4):317–322. doi: 10.1111/j.1365-2885.1994.tb00252.x. [DOI] [PubMed] [Google Scholar]
- Witkamp R. F., Nijmeijer S. M., Monshouwer M., Van Miert A. S. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig. Drug Metab Dispos. 1995 May;23(5):542–547. [PubMed] [Google Scholar]
- Wortelboer H. M., de Kruif C. A., van Iersel A. A., Falke H. E., Noordhoek J., Blaauboer B. J. The isoenzyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers. Biochem Pharmacol. 1990 Dec 1;40(11):2525–2534. doi: 10.1016/0006-2952(90)90095-3. [DOI] [PubMed] [Google Scholar]
- Wrighton S. A., Maurel P., Schuetz E. G., Watkins P. B., Young B., Guzelian P. S. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. Biochemistry. 1985 Apr 23;24(9):2171–2178. doi: 10.1021/bi00330a010. [DOI] [PubMed] [Google Scholar]
- Yang C. S., Patten C. J., Ishizaki H., Yoo J. S. Induction, purification, and characterization of cytochrome P450IIE. Methods Enzymol. 1991;206:595–603. doi: 10.1016/0076-6879(91)06129-q. [DOI] [PubMed] [Google Scholar]